Bioelectronics Corp (PK) (BIEL) News

Good MOVE!!!!

Post of the day. Going straight to stickie stardom.




BUY $BIEL$

❤️20 REASONS TO LOVE BIEL❤️
Note: Much of the following was actually provided by the #1 basher - a former Mayflower mover/insurance office staffer/proud AutoCad certificate holder (requires a few days of classes) - who acknowledges BIEL is "very close to profitability every quarter":
1. It's a real company with real products.
2. The company is not burning $$$ millions every quarter trying to get a product through the FDA wringer. They've accomplished FDA clearance (5) already.
3. The company is very close to profitability every quarter. BIEL will likely be profitable soon, it not already (a $400K quarter should do it).
4. There is no toxic debt. The company is not sinking under death spiral financing.
5. Actipatch has thousands of excellent, mostly 5-star customer reviews.
6. $40 million tax-loss carry forward will make the first $40 million in profits tax free and accelerate the path to profitability.
7. If $800k revenue is reported for 2024, it will likely gets the pps out of the trips.
8. Technical indicators (Golden Cross, Blue Sky Breakout, etc.) turning positive. Every bull run starts with this.
9. Bare bones expenses: about $750k/year for GENERAL AND ADMIN EXPENSES (salaries, utilities, R&D, Advertising, etc) with a burn rate of about $220k/year for Other Gen and Admin Expenses.
10. New utility patent (pending) for chronic pain inflammation (vagus nerve) - HUGE.
11. Actipatch will be a Standard of Care product.
12. They have 5 FDA clearances with more pending.
13. Insurance coverage is expanding - currently covered by the UK National Health Service (and Taiwan?).
14. Been in business for over 20 years and never reverse split.
15. Accepted for use by the Veterans Administration.
16. Rapidly expanding in the veterinary/pet market.
17. New contract/partner rumors swirling.
18. Amazon/Apple type of return on investment (ROI) very possible.
19. Fed forecast to cut interest rates five times this year, which benefits OTC stocks like BIEL greatly. The last time this happened (2021) BIEL surged 1,600%.
20. See 1 - 19!

PROSPECTUS
BIEL's low-cost OEM business model has put the company in position to be profitable soon (if not already) such that if the upcoming annual report confirms:
1) $800k annual revenue - this will be a significant increase from the the $700k-ish reported the previous two years and get the pps out of the trips;
2) $1.5 million annual revenue (or a $400k quarter) - this will likely achieve cash flow positive/profitability and get the pps to copper.
3) BIEL's prospects for achieving a 1,000% to 10,000% increase in pps are better than any other company on the market right now!
4) The path to profitability will be accelerated by the tax-loss carryforward of about $40 million (no tax on first $40 million profit).

BIEL GOES VIRAL if pps hits .006!
Market cap = $150 million at pps = .006, which would generate massive press (free marketing/advertising) in the news and financial media when they report that the pps increase is better than the gains in Amazon and Apple (3,000% over the past 10 years). It would solve all of BIEL's problems and create numerous opportunities for the company. The Reddit crowd would be all over it (generating massive free online marketing/advertising). If the company then declares profits would be used for a share buyback program (after paying off the loans), the pps would soar ($1+) and the rise would be sustained.

ACTIPATCH WILL BE A "STANDARD OF CARE" PRODUCT!
With FDA clearance for treatment of knee, back, wrist, hips, ankles, plantar fasciitis and all musculoskeletal pain, how can it not, especially at the low price of $35 - with a much longer battery life than the competition! The bashers don't seem to understand that the Actipatch FDA clearance allows it to be sold over the counter (without a prescription). The RecoveryRX applications (post operative pain, edema, wound care, etc.) do require a doctor order. Add in RecoveryRx-Veterinary and you have over 10 billion potential repeat customers - every adult and pet on the planet (every month). Then there is the "wellness" market, as many people use Actipatch for Restless Leg Syndrome (RLS is estimated to affect 10% of adults worldwide), menstrual pain, migraines and other "off label" aches and pains.

RECOVERYRX-VETERINARY COULD/SHOULD BE A GOLDMINE!
The Assisi Loop sells over 300/month just on Amazon @ $329, with 1/20 the battery life. Assisi Loop customers are paying the equivalent of over $6,000 when you factor in the additional cost and lower battery life, but Assisi customers seem happy to pay it based on the numerous 5-star reviews. RecoveryRx/Veterinary should be sold as a two/pack - one for the vagus nerve and the other for the area of pain.

DR. OZ
The Dr. Oz effect will be interesting, considering his recent appointment as Administrator of the Centers for Medicare and Medicaid Services. When Actipatch was featured on the Dr. Oz show, it achieved record sales and sold out the inventory.

BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100). KISS - KEEP IT SIMPLE STUPID! 💋

BIEL GONNA RUN LIKE 2021!
Everything is falling into place just like 2021. OTC bull market runs are fueled by the Fed cutting interest rates, and the Fed is now forecast to cut five times this year. Falling interest rates indicate a more accommodative money policy which makes investors more interested in the higher risk/higher reward stocks found on the OTC. The last time this happened, BIEL ran more than 1,600% to .0088. The previous BIEL runs coincided with similar OTC bull markets in 2017, 2014 and 2009.

The technical indicators come first - the Golden Cross and the Blue Sky Breakout. Then the fundamentals kick in (Taiwan, VA, Veterinary, New Zealand...). The OTC bull market has begun, as confirmed by Robinhood (favorite for OTC investors) stock outperforming Goldman Sachs (institutional favorite) 150% to 30% over the past few months. BIEL is a Reddit investors dream. Once they become aware of BIEL (via the financial press), the pps will rocket, product sales will soar, and we'll be celebrating like 2021!
https://microcapdaily.com/exciting-week-for-bioelectronics-corp-otcpink-biel/124825/

Expect a 5,000% ROI (pps = .01 from .0002) if BIEL reports a profit in a few days (2024 Annual Report) - or if management hints Q1 (2025) was profitable. This would put BIEL amongst the all-time greatest stocks.
Gemini says "a 5,000% ROI is fantastic but very rare and typically associated with high-risk investments such as penny stocks or early-stage startups".
Copilot says: "achieving a 5,000% return on investment (ROI) is rare and typically involves high-risk stocks, often in emerging industries or during market booms. Some penny stocks, for example, have been highlighted for their potential to deliver such returns".

BIEL's easiest (and most likely) path to success is to generate a $400k revenue quarter and/or a $1.5 million revenue year. There are indications this has been - or soon will be - achieved. This would achieve cash flow positive/profitability and increase the pps to copper, which would solve most of BIEL's problems and open up a world of opportunities for our company. The analyses provided below demonstrate the connection between revenues, profitability and the pps using standard analysis methods (it ain't rocket science!). Even if only 10% of the "catalysts" identified below materialize, the pps will still hit copper. This would generate a huge amount of free publicity in the financial and news media (an example of capitalism at it's finest - achieving the American Dream!), which would then lead to an exponential increase in product sales. With BIEL's low operating costs and business model, BIEL could pay off their loans quickly and then use subsequent profits to implement an aggressive stock buyback program, which could rocket the pps to $1+!

BIEL IS THE NEXT AMAZON /APPLE (in terms of ROI)!
When BIEL hits .006, the return on investment for a .0002 buy (for those of us fortunate enough to get them recently) will be about the same as the 10-year ROI (3,000%) for Amazon and Apple (stocks I sold too soon). Microsoft 10-year ROI is ONLY 900%. BIEL can hit .006 in IN THE BLINK OF AN EYE, as $1.5 annual revenue (or a $400k quarter) should do it (due to BIEL's extremely low operating costs and business model). There are many indications that this will be accomplished soon, if it hasn't been already! We know that Taiwan, the VA, South Africa and Bulgaria are in progress, as is RecoveryRx-Veterinary in Europe (with the USA pending). Canada is expanding, New Zealand sales started March 1 and hopefully Australia will soon follow. These new revenue streams should be in addition to the $700k+ earned in each of the past two years.

BIEL is a Venture Capitalist Dream! The opportunity to get in on the "next big thing", but with a company that has been in business for over 20 years (rather than a start-up). BIEL is probably the closest that any of us will get to having a venture capital kind of opportunity.
1) BIEL products have Standard of Care pain management potential for every adult and pet on the planet.
2) BIEL has 5 FDA clearances (with more pending) and the products work extremely well (some say like a miracle).
3) Upside ROI is huge (>10,000%) with minimal downside risk!
4) BIEL should be able to use their China manufacturer to ship directly to their international distributors and Viant for their USA sales to avoid tariffs.

BIEL HITS COPPER WHEN THE FOLLOWING OCCURS!
pps > .001 after management drops some positive hints. The Golden Cross (already achieved) and Blue Sky Breakout will get the technicians/chartists/Reddit crowd attention and the pps out of the trips;
pps > .01 after management drops some positive hints that convinces investors that break even/cash flow positive (annual rev = $1.5 mil) will be achieved, combined with the momentum from a 2021 like OTC run (fueled by the Reddit crowd);
pps > .04 after pr indicates the annual revs from Taiwan (in progress) can be valued at $10 mil+;
pps > .08 after pr indicates the annual revs from the VA (in progress) can be valued at $10 mil+;
pps > .12 after pr indicates the annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil+;
pps > .16 after pr indicates the annual revs from new contracts (distributors, partners, New Zealand, etc.) can be valued at $10 mil+;
Above pps values are based on P/E = 100
For P/E = 200, pps = .32
For P/E = 300, pps = .48
pps > $1 after loans are paid off and a stock buyback is initiated.

CATALYSTS (Details):
If 2024 revenues are over $800,000 (report is due in the coming days), it would be a significant improvement over the $700k-ish reported in each of the last two years, which would propel the pps out of the trips. It would also generate some positive publicity in the financial media that would spur future product sales. With the huge USA market available to BIEL last year - after KT previously tried to weaponize their exclusive US rights (2022 and 2023) against us - increased revenue is likely.

$1.5 million annual revenue (or a $400k quarter) = break even/cash flow positive = .01 pps.

Taiwan looks like it will be the first catalyst. There are over 80 public hospitals and over 400 private hospitals in Taiwan. They have national health insurance and are rated the world's number one health system.
Assume 100 Taiwan hospitals order 100 Actipatch/RecoveryRx per month @$100 each for BIEL:
$100 x 100 hospitals x 100 x 12 mo = $12,000,000 rev/year.
Using profit = $10 mil and P/E = 100: PPS = .04.
Note: RecoveryRx Veterinary also appears to be in play in Taiwan.

1000 Veterinarian Clinics (USA):
Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi):
1000 x 100 x 10 x 12 = $12,000,000 rev/year.
Note: RecoveryRx Veterinary also appears to be in play internationally.

There are over 1,000 VA facilities in the U.S. Conservatively assuming 100 VA hospitals order 100 RecoveryRx per month ($100 each for BIEL):
100 x 100 x 100 x 12 = $12,000,000 rev/year.

Sub-total for VA + VET = $20 mil and P/E = 100: PPS = .08!

TOTAL (Taiwan + VA + Veterinary + applying the tax loss carryforward):
pps = .12 (P/E = 100)
pps = .24 (P/E = 200)
pps = .36 (P/E = 300)

Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, RecoveryRx Veterinary international sales, New Zealand, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = $1).

BIEL FACT CHECK:
1) The nearly 25 billion shares outstanding is large but not a problem. It is irrelevant as it is accounted for in the VALUATION (pps) - 25 billion shares @.0002 = $5 million is the same valuation as 1 million shares at $5/share. FULL STOP

The stock market is all about valuation (outstanding shares x pps) - you buy if you think a stock is under-valued and sell if you think it is over-valued. Only amateurs/newbies do not understand this. Right now, investors feel BIEL is fairly valued between $5 - 7.5 million, but if news develops where investors feel $1 billion is fair value, you will see the BIEL pps rise accordingly (pps = .04). Apple and Amazon will soon have billions more shares outstanding than BIEL (and nobody is concerned)!

Some have tried to dispute this - without success - always changing the subject to dilution. BIEL has not diluted significantly in many years, and there is no indication it will in the future.

The low pps is actually an advantage at this point, as it makes BIEL affordable to any investor. If you have $1,200 to invest, would you rather own 6 million shares of BIEL or 1 share of O'Reilly Auto Parts? The Reddit crowd would definitely choose BIEL.

2) BIEL's valuation is currently $5 million (for revs of $715k last year), which is undervalued compared to stocks (like SERV and QUBT for example) with billion-dollar valuations but only half of BIEL's revenue.

When people become aware of the benefits of PSWT/PEMF and the huge multi-billion-dollar drug free pain management market - that desperately needs FDA cleared Actipatch/RecoveryRx/RecoveryRx Veterinary- BIEL will SOAR!

3) BIEL has been in business for over 20-years and has NEVER done a reverse split, which is VERY IMPRESSIVE!

4) Supply/Demand - the majority of the outstanding shares are in tight hands, so the pps will move up like a rocket after ignition, as the supply of available shares will be less than the demand (SQUEEZE!). Shareholders can help fuel the blast off by locking up their shares with "good until cancelled sell orders" (@$1) so their shares cannot be borrowed by the short sellers, thereby further reducing the supply.

BUYOUT
Right now, I doubt anything under $50 million would be considered (accounting for loans, etc.). That's out of my range, but in the future - after the pps increases, loans are paid off and a share buyback is implemented - I could see a point where a group of shareholders could get together and leverage their shareholdings to make an offer. Years ago, Simpsonly and some other shareholders made an offer to Andy but were turned down. Not sure if Orel Hershiser was part of that group, but he is rumored to be a shareholder and a big fan of the products (would be a great influencer for BIEL).

IS BIEL THE NEXT MSFT?
Those that bought one share of Microsoft at the IPO price of $21 saw their investment increase to $210,000 recently (10,000 X). Someone buying 1 million shares of BIEL @.0002 would see their $200 investment grow to $2,000,000 (pps = $2) with equivalent growth. Is this possible? Absolutely, after BIEL becomes profitable, pays off their loans and then implements an aggressive stock buyback program!

3331 is restricted to one post per day, which is often deleted.

Barchart is rating BIEL a buy.
‘Nuff said!




BUY $BIEL$

I do exactly the same. When he posts, I buy !!

Both bobby1151 & ddls Alias's were Born in 2009 & ddls's posts over the years are one of the main reasons that I have kept acquiring Million's of BIEL shares..
I have never seen anyone so dedicated to his trade & every time ddls posts, I buy more Biel shares as ddls is my Barometer as to Bioelectronics future & my financial success with my BIEL shares!! More later!

DonJoy Store
EME Replacement Device ( FSA / HSA APPROVED!!!!!!$$$$$$$ )
https://www.donjoystore.com/donjoyr-advantage-eme-replacement-device?srsltid=AfmBOoqJL5fv-Tkyjz7NmuwFnDcBi2nm4lqHTYznN6zlx5vaKarK8IsL

-------------------------------------------------------------------------

A new over-the-counter treatment for heel pain caused by plantar fasciitis has received clearance from the United States FDA.
https://www.footandankleps.com/blog/new-wearable-therapy-provides-heel-pain-treatment

--------------------------------------------------------------------------

Actipatch Smart Insole --- NEW & IMPROVED!!!!

https://unovita.com/products/smart-insoletm-heel-pain-relief?variant=47506240471349

https://shop.renovabiomed.it/it/prodotti/3402-soletta-e-fascia-smart-insole.html?sfnsn=wa

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

----------------------------------------------------------------------------------

RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an electromagnetic field at the point of pain that changes how cells communicate pain. Research, technical information and studies available at www.RecoveryRx.co. It is an amazing device, unlike TENS units, RecoveryRx reduces pain without any kind of electrical stimulation feeling for the veteran. The antenna lasts 30 days, all Ortho, pain management, and PT providers can work through prosthetics (RecoveryRx is on the FSS) to get these on their patients for feedback and widespread use at the VA.

https://www.reddit.com/r/VeteransAffairs/comments/1gxclby/recoveryrx_now_available_through_prosthetics_for/?utm_source=share&utm_medium=mweb3x&utm_name=mweb3xcss&utm_term=1&utm_content=share_button
____________________________________________________

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( like LYING that he/she/it has ANY amount of shares in BIEL, PRETENDING to be shareholder........i can smell those from a mile away!!! ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!

----------------------------------------------------------------------------------------------------

Territory///Distributor////Products Distributed/// Website

Australia LMT ActiPatch RecoveryRx www.actipatch.com.au
Bangladesh Multiple Health Pharma ActiPatch
Bahrain STADA ActiPatch www.stada.com
Botswana Adcock Ingram ActiPatch www.actipatch.co.za
China CICD ActiPatch
Finland Kir Fix Oy ActiPatch www.kir-fix.fi
Iran Al Mutawafiqua Modern Drug ActiPatch
Ireland Inish Pharmacy ActiPatch www.inishpharmacy.com
Italy OneGlobe Bio ActiPatch/RecoveryRx www.oneglobebio.com
Jordan Al Mutawafiqua Modern Drug ActiPatch
Kuwait Modern Development ActiPatch/RRx www.mdmedical.co
Lebanon Al Mutawafiqua Modern Drug ActiPatch
Mexico Novro Med S.A. de C.V. RecoveryRx https://globaltech.com.mx/
Oman Modern Development ActiPatch/RRx www.mdmedical.co
Qatar Modern Development ActiPatch/RRx www.mdmedical.co
Saudi Arabia STADA ActiPatch www.stada.com
Spain Acuna Fombona ActiPatch www.acuna-fombona.com
Spain PRIM Group RecoveryRx www.prim.es
South Africa Adcock Ingram ActiPatch www.actipatch.co.za
Sweden Swedish Healthcare Academy ActiPatch www.actipatch.se
Taiwan Aphrodite Bio-Medical Technology ActiPatch www.abmt.com.tw
UAE Modern Development RecoveryRx www.mdmedical.co
United Kingdom Chemist4u ActiPatch www.chemist-4-u.com/
United States BioElectronics Corp RecoveryRx www.recoveryrx.co/
United States DonJoy DonJoy Advantage www.donjoyperformance.com
Yemen Al Mutawafiqua Modern Drug ActiPatch

https://www.bielcorp.com/distributors/

-----------------------------------------------------------------------------------------------------

From 3331:
BIEL 2025 - GONNA RUN!

pps > .001 after management drops some positive hint(s) - Golden Cross (already achieved) and Blue Sky Breakout gets technicians/chartists attention and pps out of the trips;

pps > .01 after management drops positive hint(s) convincing investors that break even cash flow positive (annual rev = $1.5 mil) will be achieved, along with the momentum from a 2021 like OTC run (Reddit crowd takes notice);

pps > .04 after pr indicates annual revs from Taiwan (in progress) can be valued at $10 mil;

pps > .08 after pr indicates annual revs from VA (in progress) can be valued at $10 mil;

pps > .12 after pr indicates annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil;

pps > .16 after pr indicates annual revs from new contracts (distributors, partners, etc.) can be valued at $10 mil;

pps > $1 (2026 - 2027)after loans are paid off and a stock buyback program is initiated.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652979

-------------------------------------------------------------------------------------------------------

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY INFLUENCE FROM KNOWN PAID BASHERS / PUMPERS / LIARS / MANIPULAYTORS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :

#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!

#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but a MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!

#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing
to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!

Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!! HEHEHE.

Here are the HARD FACTS about Bioelectronics corp ( BIEL ). below , backed by LINKS, NOT some made up LIES, BS WORD SALADS, SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS to DAMAGE one's IMAGE, to INFLUENCE POTENTIAL Investors to think negative about the Company's ( BIEL ) Future, to FALL for WORD SALADS of SCARE TACTICS, with an AGENDA !!!!!!!!!!!
BIEL$$$

------------------------------------------------------------------------------------------------------------

"If you’re looking for a powerful way to enhance your vitality, recover faster, and optimize your overall well-being, I highly recommend exploring PEMF therapy. It’s an investment in your health and a key component of my own personal journey towards peak performance.”

– Tony Robbins

Tony uses a high powered $25,000 PEMF machine but anyone can sample some of PEMF's capabilities with a $30 ActiPatch.

http://54.219.205.59/2023/07/17/the-energy-machine-that-powers-tony-robbins-exploring-the-transformative-power-of-pemf-therapy/

------------------------------------------------------------------------------------------------------------

Note, while NOPAIN ACT is a PREDICTION, YET, it is still a HARD FACT and VERY DOABLE!!!!!!!!

NOPAIN Act
Jan. 1, 2025
https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).

“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—

“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or

II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.

“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—

“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or

“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;

that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>

Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—

(1) by aligning the margins of clause (v) with the margins of clause (iv);

(2) by redesignating clause (vi) as clause (vii); and

(3) by inserting after clause (v) the following new clause:

“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.

(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—

Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—

(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and

(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>

(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.

(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
___________________________________________________________________

The Pain Relief Therapy Market is characterized by a diverse competitive landscape, with several leading companies influencing market trends and driving innovation. Notable players include:

Stimwave: Specializes in innovative neuromodulation devices designed for chronic pain management, focusing on minimally invasive procedures to enhance patient outcomes.

Merk & co: A global leader in pharmaceutical products, Merck is actively involved in developing new analgesics and expanding its portfolio to address unmet medical needs in pain management.

Sanofi: Known for its wide range of pharmaceutical products, Sanofi is committed to advancing pain relief therapies through research and strategic partnerships.

Endo Pharmaceuticals.: Focused on pain management solutions, Endo is leveraging its expertise to develop unique formulations that cater to varying patient needs.

Calmare Therapeutics: Recognized for its innovative non-invasive pain relief technology, Calmare Therapeutics is pioneering new approaches to chronic pain treatment.

Johnson & Johnson: A key player in the healthcare sector, Johnson & Johnson is expanding its pain relief offerings through a combination of product innovation and strategic acquisitions.

Abbott: Engaged in developing advanced pain relief systems, Abbott is at the forefront of creating integrated solutions that combine medical devices and pharmaceuticals.

Allergan: Known for its aesthetic and therapeutic products, Allergan is also exploring pain relief therapies, particularly in the realm of nerve block techniques.

Beiersdorf: While primarily recognized for its skincare products, Beiersdorf is venturing into the pain relief market with topical analgesics and other innovative solutions.

Hisamitsu.: A leader in transdermal drug delivery systems, Hisamitsu is focused on developing patch-based pain relief solutions.

UltraCare Pro: Specializes in therapeutic modalities that enhance pain management through non-invasive techniques.

Iskra Medical.: Develops medical devices that facilitate pain relief, particularly in physiotherapy and rehabilitation settings.

Bioelectronics Corp: Innovates in the field of electroceuticals, offering non-drug solutions for pain management .

Medline : A major player in the healthcare supply chain, Medline is expanding its product offerings to include pain management solutions.

Pfizer: Actively involved in researching and developing new pain relief medications to address chronic pain issues.

Each of these companies plays a vital role in shaping the Pain Relief Therapy Market through product innovations, market expansions, and strategic partnerships, contributing to the overall growth and development of the sector.

Moreover, consumer awareness regarding pain management options is on the rise. Patients are becoming more informed about their choices, leading to increased demand for customized solutions that cater to individual needs. This trend is prompting companies to focus on product customization and the development of tailored therapies.

Emerging technologies, such as wearable devices and Internet of Things (IoT) solutions, are also shaping the future of the Pain Relief Therapy Market. These innovations allow for continuous monitoring of patients' conditions, enabling timely interventions and adjustments to treatment plans based on real-time data.
https://www.openpr.com/news/3785778/pain-relief-therapy-market-industry-dynamics-and-contributions

__________________________________________________________________

CY 2025 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS 1809-P)
“Access to Non-Opioid Treatments for Pain Relief
…We are proposing that seven drugs and one device qualify as non-opioid treatments for pain relief, and we propose these products be paid separately in both the HOPD and ASC settings starting in CY 2025…”
https://www.cms.gov/newsroom/fact-sheets/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center

CONCLUSION
"The medical device market is poised for significant growth across all major regions, driven by technological advancements, increasing healthcare spending, and a global focus on improving healthcare outcomes. London and the UK continue to position themselves as leaders in medical device innovation, while Europe remains a regulatory-driven but stable market. Asia offers the most dynamic growth opportunities, with countries like China and India playing pivotal roles. Meanwhile, the USA maintains its dominance as the largest medical device market, supported by advanced R&D and regulatory frameworks. Investors looking to capitalize on these trends should consider region-specific opportunities, keeping an eye on the evolving regulatory landscapes and technological innovations shaping the industry."
https://iotworldmagazine.com/2024/09/05/2420/a-review-of-medical-device-market-size-reports-2024-2025-in-london-u-europe-asia-and-usa-focused-on-growth-forecast-and-segments

REFERENCES
Fortune Business Insights: https://www.fortunebusinessinsights.com/
MarketsandMarkets: https://www.marketsandmarkets.com/
Mordor Intelligence: https://www.mordorintelligence.com/
Gov.UK: https://www.gov.uk/
GlobalData: https://www.globaldata.com/
TechNavio: https://www.technavio.com/
Statista: https://www.statista.com/
Emergo: https://www.emergobyul.com/
Frost & Sullivan: https://www.frost.com/
Allied Market Research: https://www.alliedmarketresearch.com/
BMI Research: https://www.bmiresearch.com/
IBISWorld: https://www.ibisworld.com/
McKinsey: https://www.mckinsey.com/
Grand View Research: https://www.grandviewresearch.com/

----------------------------------

Globe Newswire via NewsMeiaWire
Sree Koneru, PhD Joins the Board of BioElectronics Corporation
FREDERICK, MD December 3, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC:
BIEL a developer of medical technology products, today announces that Sree Koneru, PhD, will join its Board of Directors, effective December 3, 2024. Upon Dr. Koneru’s appointment, the Board will consist of three members, including Kelly Whelan, President of BioElectronics, and its Chairman, Richard Staelin, PhD.
https://www.facebook.com/story.php?story_fbid=1120914580039912&id=100063641406505
___________________________________________________

Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing

PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation

FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.

https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE

Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/

MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/
___________________________________________________________

News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024

https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
_________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )


A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.
Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.
https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408


BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

Ortho Alliance, 11 Orthopedic Surgery Centers, 'Optimal Recovery' with Pre/Post-Op RecoveryRx
https://orthoalliance.com/optimal-recovery/

Smart Approach Recovery
https://recoveryrx.carrd.co/

Kelly Cove Mobility
https://youtu.be/jljs7QPX7KE

RecoveryRx Veterinary
https://rrxvet.carrd.co/

TES Veterinary Physiotherapist
https://vetphysiodevon.com/vet-recovery-rx

Actipatch Taiwan
https://www.actipatchtw.com/general-1

Actipatch Sweden
https://rehabat.se/products/actipatch-mot-muskel-och-ledsmarta-och-kna-och-ryggsmarta

Actipatch Italy
https://alaction.it/

Actipatch Bulgaria
https://actipatch.bg/

Actipatch Finland
https://www.facebook.com/watch/?mibextid=SphRi8&v=1026096241843857&rdid=0EAph2C6CZ4xryHY

ActiPatch STADA
https://www.linkedin.com/posts/kelly-whelan-5ba88115_distribution-painrelief-stada-ugcPost-7274483449602748417-__ZB/

BIEL announces publication of Canine OA Study
https://finance.yahoo.com/news/bioelectronics-corporation-announces-publication-canine-124500399.html

Vagus Nerve Patent Application Filing RecoveryRx
https://www.newmediawire.com/news/bioelectronics-corporation-announces-utility-patent-application-filing-7075138

________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/

Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity

Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE

Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC

WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/


" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------
Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!

National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........


Context/Background:

Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.

Objective/Purpose:
The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.

Results:
An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.

Ranking:
The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].

Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:
1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.

2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf

___________________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recoverry
rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity

Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

___________________________________________________________

Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://www.instagram.com/skymedicalsupply/p/C6J0wXQCGLF/
___________________________________________________________

Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091

_________________________________________________________

Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa

#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical
https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

__________________________________________________________________

Chairman Updates Investors
Outlines Sales Activities, Clinical Trials, and a potential legal Action Against MundiPharma
FREDERICK, MD. October 16, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire
https://www.facebook.com/BioElectronics/

BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST

https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________

Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate
https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html

____________________________________________________________
CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid
=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI

____________________________________________

ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:
http://actipatch.com 📷

No More Dangerous, Addictive or Expensive Drugs.
https://twitter.com/ActiPatch/status/1752421581769363689?s=20

___________________________________________________________________

ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain

https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351


ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!

11/20/2023
Washington State poised to extend coverage for SCS

https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________

ActiPatch SA
February, 6 at 1:35 Am
Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief#BackPainRelief
https://www.facebook.com/watch/?v=1124676815379216

__________________________________________________________________

NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!
https://www.neuromodulation.org/news/closed-loop-04172023

_______________________________________________________________

ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at:
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep

https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351

___________________________________________________________

Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!
https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

_____________________________________________________________

ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5

Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC

WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/


ActiPatch SA
tnepdosrSo810ii
There's a champion inside all of us – don’t let chronic pain hold you back! If life is the #2024Olympics, then ActiPatch® is your #1 supporter. 💪
https://www.facebook.com/watch/?mibextid=oFDknk&v=1038405881014609&rdid=FMmcKKO2DsmHYISt

You might have thought chronic pain would be with you for life, but now there's something that can help. 🌟 Meet ActiPatch®: pain relief
https://www.facebook.com/watch/?mibextid=CYgPv5&v=909395761002533&rdid=cqiPcvFNpcuizRNh


SAI, Airway, KT, have all renewed their 'FDA Establishment Registration' to sell ActiPatch for 2025


Name .......................................................................... Reg # ... Year
AIRWAY SURGICAL APPLIANCES LTD. CANADA .... 9611956 2025

KT Health, LLC UT/USA .........................................3007282994 2025

SURGICAL APPLIANCE INDUSTRIES, INC. OH/USA 1511629 2025

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm ("PQY" product code)


_________________________________________________________

PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center
https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

----------------------------------------------------------------------------------------

BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers

Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.

Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00

https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ

https://link.springer.com/article/10.1007/s42399-020-00652-y

---------------------------------------------------------------------------------------------------

New product added
https://actipatch.com/buy-1

BioElectronics’ pulsed shortwave therapy device
is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Top5-USA.co
Top 5 Actipatch In The US

https://www.top5-usa.com/actipatch

------------------------------------------------------------------------------------------------------

RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.

https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-----------------------------------------------------------------------------------------------------------

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

"RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx."
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE


"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------

Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity


Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

----------------------------------------------------------------------------------------------------------

Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC


Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

----------------------------------------------------------------------------------------------------

From 3331:
WHICH CATALYST WILL BE FIRST?
:

1000 Veterinarian Clinics (USA):
Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi):
1000 x 100 x 10 x 12 = $12,000,000 rev/year.

100 VA Hospitals:
Conservatively assume each hospital orders 100 RecoveryRx per month ($100 each for BIEL):
100 x 100 x 100 x 12 = $12,000,000 rev/year.


Using profit = $20 mil and P/E = 100:
PPS = .08!

Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = .25 to $1?).

ADDITIONAL CATALYST:
Here are some additional numbers using Taiwan as a catalyst, using beacham's conservative numbers of 1% market penetration w/$10 profit/unit yields $43 million revenue:

$3 million = break even, cash flow positive: pps = .01.
Each additional $2.5 million/year should result in an additional .01 increase in pps (P/E = 100).

For revenue = $43 million, profit = $40 million (and applying the tax loss carryforward), resulting pps =
.16 (P/E = 100)
.32 (P/E = 200)
.48 (P/E = 300)

However, there are several factors that indicate this estimate might be extremely conservative, such as:
1) Taiwan appears to be using the RecoveryRx (requires doctor approval) version of Actipatch (OTC), which would have a higher profit than $10/unit.
2) market penetration will likely be higher than 1%.

Therefore, a case could be made for increasing the above estimates 10-fold or more (although tax would then need to be factored in). Now factor in the VA, veterinary, and other rumored contracts (if they materialize), and you're taking some serious money!

ANOTHER BIEL VALUATION MEASURE: QUBT hit $27/share recently, even though their revenue last year ($358k) was half that of BIEL ($715k). Accounting for the difference in outstanding shares (25 bil vs 100 mil), BIEL pps = .10 is the equivalent valuation to QUBT = $27/share.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175566191

Well, I am thinking that the financials have been misplaced. It could happen to anyone.

So that's a little over 700 smackers ($) traded today! Yeah, this is SMOKIN!

What this really is ------- is SAD -- REAL SAD!

4/21 - 4/25 .. Buys 30,460,647, Sells 63,702,584...😭

Toda looks good doesn't it ddls!!!!!!!!!!!!!!!!!!!!!!

4/25/25: Buy: 2,070,000, Neutral: 350,000, Sell: 0

Well, I would have to say that zombie biel had a very good week!!! Even with all of the chaos caused by the big orange head in DC the price per share never dipped below .0001 cents. Kudos to the long suffering biel shareholders!!!........................By the way, has anyone seen the financials? They seem to have gotten lost!

The last trade was a two million share buy at .0003. Someone knows something.

Looks like a market maker dropped Biel from 0.0003 to 0.00025 with an $87.50 possible cost strange!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

😀SALES-TRACK SHOWS STEEP SALES DECLINES AT BIEL😀

Sales are slower than the server at this site.

Art, just maybe there is another REASON!!!!!! We shall soon know!!

Another one of your famous comic book posts?

Meanwhile, one trade..Buy: 70,000, Neutral: 0, Sell: 0

He didn't realize he was making that admission.

Now we're discussing whether or not copy/pasting someone's literal quote is "quoting" that person. Doesn't matter what the quote said.... we're diverting attention away from the content and focusing on semantics.

Bottom line: the company has no money, can't afford to do any research or maintain assets or pay employees or even pay annual Corporation fees and has lost all but one Officer. The remaining Officer, the CEO/CFO/President, spends 3-4 hours a day on FaceBook and insists she's working hard.

At least she's posting as herself again. For awhile she was posting as "ActiPatch Customer Service" and pretending it wasn't her.

I wish ol' FauxPilot Freddy would go back to FB. Those were some good times. He offered to work 60 hours a week for free as VP of Everything, but he ran away when Kelly and Lauren pressed him for details.

Maybe they figured out that he gets out of bed at the crack of noon every day.


BIEL

You two psycho's do know these debates are irrelevant?

You should shit can it for a while and worry about this junk company going into BK or FKA.....SOON

If I were either one of you, you should junk sell the junk and move on, that's if your ego allows it.

So you think she didn't actually say that? Why did you copy her quote then?

LOL


BIEL

>>>Spending day and night being obsessed with Kelly and her company<<<


LOL, this from someone 'obsessed' to the point of trying to find the true identity of a poster on a stock message board! --- Remember?

Why would anyone care about that and why would it matter? Probably due only to one's 'obsession' --- NO?

>>>It is pretty clear that this is caused by the costs of renewing and BIEL's need to conserve resources.<<<


You do not see how BAD that is for the stockholders of this company to hear? REALLY, THAT is supposed to make them feel better about why the no renewal? Because they do not have enough money and need to reserve funds? How worse of an excuse could there be and to hear, for those that have invested in this company, that they do not have enough money? And that excuse from management (no funds) has been used a few times before, as in lack of advertising and no more official PR's that reach the market.

So OK, now the stockholders should feel better for THAT reason why they have not renewed the corporation? ---- WOW!

This is sad ----- real sad!

So they literally cannot afford to keep the lights on and do the most basic things to be a publicly traded company but somehow they are to have millions in revenue to enrich shareholders?
That is delusional at best and a straight up lie at worst.

LOL, that is a quote in the original PR, Good Grief

>

Read the original PR.

https://www.globenewswire.com/news-release/2024/12/03/2990600/0/en/Sree-Koneru-PhD-Joins-the-Board-of-Directors-of-BioElectronics-Corporation.html

Still trying for that 1 to 2 flip I see, does not look good with all of the shares available and transacting at 2 Nope, I have no BIEL buy orders. I don't want it at any price right now -- too many good deals available elsewhere. Why let money rot in BIEL? (and BIEL trading at 2 is your pump du jour?) BIEL has been down the Incorporation Forfeiture/Revival road before. Yes and what does that tell you about BIEL Management? Forfeiture 10/03/2022, 8 months later, Revival 6/21/2023. It is pretty clear that this is caused by the costs of renewing and BIEL's need to conserve resources. Notice that the comptroller lifted the Objection in March the last time, but has not lifted the Objection yet this time. But more important: "need to conserve resources?" You pumpers have been yammering about Taiwan and Veterinarians and the VA for months. BIEL still can't afford to revive the Corporation in Maryland? Really? It's pretty clear, then, that YOU think Taiwan, the Vets, and the OTHER Vets are all just bullshit. OK. Good to know. No one was quoted, I posted the BIEL PR proving that Sree was a BIEL BOD member Yes and you quoted Kelly Whelan when you reprinted that PR. Read it again. See the quotation marks?

I repeat: there is no Corporation; therefore, there is no BOD. I notice you're not refuting that.


BIEL

Well even if any of these studies were successful, no one is buying any of zombie biel's gadgets. And even if there was revenue, what kind of ratio would result when divided by 24 billion shares. Nothing will move the needle. If the longs would be lucky and get a price per share "pop" to .0005 it would be time to dump. Having said that, I doubt that a "pop" will ever happen. Where are the financials and why the delay? The biel longs have bought a pig in a poke.

Still trying for that 1 to 2 flip I see, does not look good with all of the shares available and transacting at 2

<<<<< There is no Corporation because the Corporation is Forfeited. >>>>>

BIEL has been down the Incorporation Forfeiture/Revival road before. Forfeiture 10/03/2022, 8 months later, Revival 6/21/2023. It is pretty clear that this is caused by the costs of renewing and BIEL's need to conserve resources.

<<<< you quoted Whelan saying >>>>

No one was quoted, I posted the BIEL PR proving that Sree was a BIEL BOD member, due to your BFF Art ignoring that fact. Typical GSO tactic of going 'Off Topic' to bash BIEL.

You're so perfect GS, you know all BIEL'S fine details.

For some reason.😎

Stanford wasn't carpal tunnel. It was thumb OA. Specifically, thumb carpometacarpal joint osteoarthritis.

https://clinicaltrials.gov/study/NCT05315297

On clinicaltrials.gov, the researchers are supposed to post their results within one year after the primary completion date, which would be 08/31/2025, but sometimes researchers don't post results on clinicaltrials.gov and there doesn't seem to be consequences for not posting. So, we might see the results "soon" and we might never see the results.

But who cares about this 60-patient Stanford trial or, for that matter, the 10-patient Italian carpal tunnel "Observational Study?" The device already has full body OTC clearance for pain. Do you think doctors will read either study and prescribe the device? Because any doctors reading that research will ALSO read Ilfeld's 119-patient opioid study. Remember how bad Ilfeld's results were? Maybe you should look again.

https://clinicaltrials.gov/study/NCT05399355?tab=results

Looking forward to your "PROSPECTUS" after we see those 2024 financial numbers! Granted, we might not see those numbers for three more weeks, but we'll see them eventually, and then you'll have to re-write your script. Maybe you should start now.

And you should take your act back to FaceBook! I think the Whelan Sisters are ready to forgive you. We'd all love to see you offer to be the non-paid "VP of Everything" again! You said you'd work 60 hours a week for free. That was fun. Has it been a year already?


BIEL

DonJoy Store
EME Replacement Device ( FSA / HSA APPROVED!!!!!!$$$$$$$ )
https://www.donjoystore.com/donjoyr-advantage-eme-replacement-device?srsltid=AfmBOoqJL5fv-Tkyjz7NmuwFnDcBi2nm4lqHTYznN6zlx5vaKarK8IsL

------------------------------------------------------------------------

A new over-the-counter treatment for heel pain caused by plantar fasciitis has received clearance from the United States FDA.
https://www.footandankleps.com/blog/new-wearable-therapy-provides-heel-pain-treatment

--------------------------------------------------------------------------

Actipatch Smart Insole -- NEW & IMPROVED!!!

https://unovita.com/products/smart-insoletm-heel-pain-relief?variant=47506240471349

https://shop.renovabiomed.it/it/prodotti/3402-soletta-e-fascia-smart-insole.html?sfnsn=wa

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

----------------------------------------------------------------

RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an electromagnetic field at the point of pain that changes how cells communicate pain. Research, technical information and studies available at www.RecoveryRx.co. It is an amazing device, unlike TENS units, RecoveryRx reduces pain without any kind of electrical stimulation feeling for the veteran. The antenna lasts 30 days, all Ortho, pain management, and PT providers can work through prosthetics (RecoveryRx is on the FSS) to get these on their patients for feedback and widespread use at the VA.

https://www.reddit.com/r/VeteransAffairs/comments/1gxclby/recoveryrx_now_available_through_prosthetics_for/?utm_source=share&utm_medium=mweb3x&utm_name=mweb3xcss&utm_term=1&utm_content=share_button
____________________________________________________

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 10 years since Oct. 2015 and counting?? ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!


-----------------------------------------------------------------------------------------------------

Territory///Distributor////Products Distributed/// Website

Australia LMT ActiPatch RecoveryRx www.actipatch.com.au
Bangladesh Multiple Health Pharma ActiPatch
Bahrain STADA ActiPatch www.stada.com
Botswana Adcock Ingram ActiPatch www.actipatch.co.za
China CICD ActiPatch
Finland Kir Fix Oy ActiPatch www.kir-fix.fi
Iran Al Mutawafiqua Modern Drug ActiPatch
Ireland Inish Pharmacy ActiPatch www.inishpharmacy.com
Italy OneGlobe Bio ActiPatch/RecoveryRx www.oneglobebio.com
Jordan Al Mutawafiqua Modern Drug ActiPatch
Kuwait Modern Development ActiPatch/RRx www.mdmedical.co
Lebanon Al Mutawafiqua Modern Drug ActiPatch
Mexico Novro Med S.A. de C.V. RecoveryRx https://globaltech.com.mx/
Oman Modern Development ActiPatch/RRx www.mdmedical.co
Qatar Modern Development ActiPatch/RRx www.mdmedical.co
Saudi Arabia STADA ActiPatch www.stada.com
Spain Acuna Fombona ActiPatch www.acuna-fombona.com
Spain PRIM Group RecoveryRx www.prim.es
South Africa Adcock Ingram ActiPatch www.actipatch.co.za
Sweden Swedish Healthcare Academy ActiPatch www.actipatch.se
Taiwan Aphrodite Bio-Medical Technology ActiPatch www.abmt.com.tw
UAE Modern Development RecoveryRx www.mdmedical.co
United Kingdom Chemist4u ActiPatch www.chemist-4-u.com/
United States BioElectronics Corp RecoveryRx www.recoveryrx.co/
United States DonJoy DonJoy Advantage www.donjoyperformance.com
Yemen Al Mutawafiqua Modern Drug ActiPatch

https://www.bielcorp.com/distributors/

---------------------------------------------------------------------------------------------

From 3331:
BIEL 2025 - GONNA RUN!

pps > .001 after management drops some positive hint(s) - Golden Cross (already achieved) and Blue Sky Breakout gets technicians/chartists attention and pps out of the trips;

pps > .01 after management drops positive hint(s) convincing investors that break even cash flow positive (annual rev = $1.5 mil) will be achieved, along with the momentum from a 2021 like OTC run (Reddit crowd takes notice);

pps > .04 after pr indicates annual revs from Taiwan (in progress) can be valued at $10 mil;

pps > .08 after pr indicates annual revs from VA (in progress) can be valued at $10 mil;

pps > .12 after pr indicates annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil;

pps > .16 after pr indicates annual revs from new contracts (distributors, partners, etc.) can be valued at $10 mil;

pps > $1 (2026 - 2027)after loans are paid off and a stock buyback program is initiated.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652979

--------------------------------------------------------------------------------------------------------------

ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY INFLUENCE FROM KNOWN PAID BASHERS / PUMPERS / LIARS / MANIPULAYTORS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :

#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!

#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but a MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!

#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing
to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!

Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!! HEHEHE.

Here are the HARD FACTS about Bioelectronics corp ( BIEL ). below , backed by LINKS, NOT some made up LIES, BS WORD SALADS, SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS to DAMAGE one's IMAGE, to INFLUENCE POTENTIAL Investors to think negative about the Company's ( BIEL ) Future, to FALL for WORD SALADS of SCARE TACTICS, with an AGENDA !!!!!!!!!!!
BIEL$$$

------------------------------------------------------------------------------------------------------------

"If you’re looking for a powerful way to enhance your vitality, recover faster, and optimize your overall well-being, I highly recommend exploring PEMF therapy. It’s an investment in your health and a key component of my own personal journey towards peak performance.”

– Tony Robbins

Tony uses a high powered $25,000 PEMF machine but anyone can sample some of PEMF's capabilities with a $30 ActiPatch.

http://54.219.205.59/2023/07/17/the-energy-machine-that-powers-tony-robbins-exploring-the-transformative-power-of-pemf-therapy/

------------------------------------------------------------------------------------------------------------

Note, while NOPAIN ACT is a PREDICTION, YET, it is still a HARD FACT and VERY DOABLE!!!!!!!!

NOPAIN Act
Jan. 1, 2025
https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).

“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—

“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or

II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.

“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—

“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or

“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;

that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>

Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—

(1) by aligning the margins of clause (v) with the margins of clause (iv);

(2) by redesignating clause (vi) as clause (vii); and

(3) by inserting after clause (v) the following new clause:

“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.

(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—

Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—

(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and

(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>

(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.

(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
___________________________________________________________________

The Pain Relief Therapy Market is characterized by a diverse competitive landscape, with several leading companies influencing market trends and driving innovation. Notable players include:

Stimwave: Specializes in innovative neuromodulation devices designed for chronic pain management, focusing on minimally invasive procedures to enhance patient outcomes.

Merk & co: A global leader in pharmaceutical products, Merck is actively involved in developing new analgesics and expanding its portfolio to address unmet medical needs in pain management.

Sanofi: Known for its wide range of pharmaceutical products, Sanofi is committed to advancing pain relief therapies through research and strategic partnerships.

Endo Pharmaceuticals.: Focused on pain management solutions, Endo is leveraging its expertise to develop unique formulations that cater to varying patient needs.

Calmare Therapeutics: Recognized for its innovative non-invasive pain relief technology, Calmare Therapeutics is pioneering new approaches to chronic pain treatment.

Johnson & Johnson: A key player in the healthcare sector, Johnson & Johnson is expanding its pain relief offerings through a combination of product innovation and strategic acquisitions.

Abbott: Engaged in developing advanced pain relief systems, Abbott is at the forefront of creating integrated solutions that combine medical devices and pharmaceuticals.

Allergan: Known for its aesthetic and therapeutic products, Allergan is also exploring pain relief therapies, particularly in the realm of nerve block techniques.

Beiersdorf: While primarily recognized for its skincare products, Beiersdorf is venturing into the pain relief market with topical analgesics and other innovative solutions.

Hisamitsu.: A leader in transdermal drug delivery systems, Hisamitsu is focused on developing patch-based pain relief solutions.

UltraCare Pro: Specializes in therapeutic modalities that enhance pain management through non-invasive techniques.

Iskra Medical.: Develops medical devices that facilitate pain relief, particularly in physiotherapy and rehabilitation settings.

Bioelectronics Corp: Innovates in the field of electroceuticals, offering non-drug solutions for pain management .

Medline : A major player in the healthcare supply chain, Medline is expanding its product offerings to include pain management solutions.

Pfizer: Actively involved in researching and developing new pain relief medications to address chronic pain issues.

Each of these companies plays a vital role in shaping the Pain Relief Therapy Market through product innovations, market expansions, and strategic partnerships, contributing to the overall growth and development of the sector.

Moreover, consumer awareness regarding pain management options is on the rise. Patients are becoming more informed about their choices, leading to increased demand for customized solutions that cater to individual needs. This trend is prompting companies to focus on product customization and the development of tailored therapies.

Emerging technologies, such as wearable devices and Internet of Things (IoT) solutions, are also shaping the future of the Pain Relief Therapy Market. These innovations allow for continuous monitoring of patients' conditions, enabling timely interventions and adjustments to treatment plans based on real-time data.
https://www.openpr.com/news/3785778/pain-relief-therapy-market-industry-dynamics-and-contributions

__________________________________________________________________

CY 2025 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS 1809-P)
“Access to Non-Opioid Treatments for Pain Relief
…We are proposing that seven drugs and one device qualify as non-opioid treatments for pain relief, and we propose these products be paid separately in both the HOPD and ASC settings starting in CY 2025…”
https://www.cms.gov/newsroom/fact-sheets/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center

CONCLUSION
"The medical device market is poised for significant growth across all major regions, driven by technological advancements, increasing healthcare spending, and a global focus on improving healthcare outcomes. London and the UK continue to position themselves as leaders in medical device innovation, while Europe remains a regulatory-driven but stable market. Asia offers the most dynamic growth opportunities, with countries like China and India playing pivotal roles. Meanwhile, the USA maintains its dominance as the largest medical device market, supported by advanced R&D and regulatory frameworks. Investors looking to capitalize on these trends should consider region-specific opportunities, keeping an eye on the evolving regulatory landscapes and technological innovations shaping the industry."
https://iotworldmagazine.com/2024/09/05/2420/a-review-of-medical-device-market-size-reports-2024-2025-in-london-u-europe-asia-and-usa-focused-on-growth-forecast-and-segments

REFERENCES
Fortune Business Insights: https://www.fortunebusinessinsights.com/
MarketsandMarkets: https://www.marketsandmarkets.com/
Mordor Intelligence: https://www.mordorintelligence.com/
Gov.UK: https://www.gov.uk/
GlobalData: https://www.globaldata.com/
TechNavio: https://www.technavio.com/
Statista: https://www.statista.com/
Emergo: https://www.emergobyul.com/
Frost & Sullivan: https://www.frost.com/
Allied Market Research: https://www.alliedmarketresearch.com/
BMI Research: https://www.bmiresearch.com/
IBISWorld: https://www.ibisworld.com/
McKinsey: https://www.mckinsey.com/
Grand View Research: https://www.grandviewresearch.com/

----------------------------------

Globe Newswire via NewsMeiaWire
Sree Koneru, PhD Joins the Board of BioElectronics Corporation
FREDERICK, MD December 3, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC:
BIEL a developer of medical technology products, today announces that Sree Koneru, PhD, will join its Board of Directors, effective December 3, 2024. Upon Dr. Koneru’s appointment, the Board will consist of three members, including Kelly Whelan, President of BioElectronics, and its Chairman, Richard Staelin, PhD.
https://www.facebook.com/story.php?story_fbid=1120914580039912&id=100063641406505
___________________________________________________

Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing

PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation

FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.

https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE

Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/

MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/
___________________________________________________________

News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024

https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
_________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )


A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.
Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.
https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408


BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

Ortho Alliance, 11 Orthopedic Surgery Centers, 'Optimal Recovery' with Pre/Post-Op RecoveryRx
https://orthoalliance.com/optimal-recovery/

Smart Approach Recovery
https://recoveryrx.carrd.co/

Kelly Cove Mobility
https://youtu.be/jljs7QPX7KE

RecoveryRx Veterinary
https://rrxvet.carrd.co/

TES Veterinary Physiotherapist
https://vetphysiodevon.com/vet-recovery-rx

Actipatch Taiwan
https://www.actipatchtw.com/general-1

Actipatch Sweden
https://rehabat.se/products/actipatch-mot-muskel-och-ledsmarta-och-kna-och-ryggsmarta

Actipatch Italy
https://alaction.it/

Actipatch Bulgaria
https://actipatch.bg/

Actipatch Finland
https://www.facebook.com/watch/?mibextid=SphRi8&v=1026096241843857&rdid=0EAph2C6CZ4xryHY

ActiPatch STADA
https://www.linkedin.com/posts/kelly-whelan-5ba88115_distribution-painrelief-stada-ugcPost-7274483449602748417-__ZB/

BIEL announces publication of Canine OA Study
https://finance.yahoo.com/news/bioelectronics-corporation-announces-publication-canine-124500399.html

Vagus Nerve Patent Application Filing RecoveryRx
https://www.newmediawire.com/news/bioelectronics-corporation-announces-utility-patent-application-filing-7075138

________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/

Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity

Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE

Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC

WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/


" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------
Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!

National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........


Context/Background:

Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.

Objective/Purpose:
The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.

Results:
An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.

Ranking:
The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].

Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:
1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.

2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf

___________________________________________________________

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recoverry
rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity

Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

___________________________________________________________

Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://www.instagram.com/skymedicalsupply/p/C6J0wXQCGLF/
___________________________________________________________

Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091

_________________________________________________________

Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa

#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical
https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

__________________________________________________________________

Chairman Updates Investors
Outlines Sales Activities, Clinical Trials, and a potential legal Action Against MundiPharma
FREDERICK, MD. October 16, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire
https://www.facebook.com/BioElectronics/

BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST

https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________

Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate
https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html

____________________________________________________________
CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid
=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI

____________________________________________

ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:
http://actipatch.com 📷

No More Dangerous, Addictive or Expensive Drugs.
https://twitter.com/ActiPatch/status/1752421581769363689?s=20

___________________________________________________________________

ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain

https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351


ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!

11/20/2023
Washington State poised to extend coverage for SCS

https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________

ActiPatch SA
February, 6 at 1:35 Am
Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief#BackPainRelief
https://www.facebook.com/watch/?v=1124676815379216

__________________________________________________________________

NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!
https://www.neuromodulation.org/news/closed-loop-04172023

_______________________________________________________________

ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at:
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep

https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351

___________________________________________________________

Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!
https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

_____________________________________________________________

ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5

Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC

WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/


ActiPatch SA
tnepdosrSo810ii
There's a champion inside all of us – don’t let chronic pain hold you back! If life is the #2024Olympics, then ActiPatch® is your #1 supporter. 💪
https://www.facebook.com/watch/?mibextid=oFDknk&v=1038405881014609&rdid=FMmcKKO2DsmHYISt

You might have thought chronic pain would be with you for life, but now there's something that can help. 🌟 Meet ActiPatch®: pain relief
https://www.facebook.com/watch/?mibextid=CYgPv5&v=909395761002533&rdid=cqiPcvFNpcuizRNh


SAI, Airway, KT, have all renewed their 'FDA Establishment Registration' to sell ActiPatch for 2025


Name .......................................................................... Reg # ... Year
AIRWAY SURGICAL APPLIANCES LTD. CANADA .... 9611956 2025

KT Health, LLC UT/USA .........................................3007282994 2025

SURGICAL APPLIANCE INDUSTRIES, INC. OH/USA 1511629 2025

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm ("PQY" product code)


_________________________________________________________

PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center
https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial

BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

----------------------------------------------------------------------------------------

BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers

Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.

Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00

https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ

https://link.springer.com/article/10.1007/s42399-020-00652-y

---------------------------------------------------------------------------------------------------

New product added
https://actipatch.com/buy-1

BioElectronics’ pulsed shortwave therapy device
is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/

MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------------

Top5-USA.co
Top 5 Actipatch In The US

https://www.top5-usa.com/actipatch

------------------------------------------------------------------------------------------------------

RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.

https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-----------------------------------------------------------------------------------------------------------

This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

"RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx."
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs

A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!!
https://veteranrecovery.org/

Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/

BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE


"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------------

Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==

BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

-------------------------------------------------------------------------------------
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )

INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity


Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst

PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/

Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg

"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/

----------------------------------------------------------------------------------------------------------

Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC


Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

From 3331:
WHICH CATALYST WILL BE FIRST?
:

1000 Veterinarian Clinics (USA):
Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi):
1000 x 100 x 10 x 12 = $12,000,000 rev/year.

100 VA Hospitals:
Conservatively assume each hospital orders 100 RecoveryRx per month ($100 each for BIEL):
100 x 100 x 100 x 12 = $12,000,000 rev/year.


Using profit = $20 mil and P/E = 100:
PPS = .08!

Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = .25 to $1?).

ADDITIONAL CATALYST:
Here are some additional numbers using Taiwan as a catalyst, using beacham's conservative numbers of 1% market penetration w/$10 profit/unit yields $43 million revenue:

$3 million = break even, cash flow positive: pps = .01.
Each additional $2.5 million/year should result in an additional .01 increase in pps (P/E = 100).

For revenue = $43 million, profit = $40 million (and applying the tax loss carryforward), resulting pps =
.16 (P/E = 100)
.32 (P/E = 200)
.48 (P/E = 300)

However, there are several factors that indicate this estimate might be extremely conservative, such as:
1) Taiwan appears to be using the RecoveryRx (requires doctor approval) version of Actipatch (OTC), which would have a higher profit than $10/unit.
2) market penetration will likely be higher than 1%.

Therefore, a case could be made for increasing the above estimates 10-fold or more (although tax would then need to be factored in). Now factor in the VA, veterinary, and other rumored contracts (if they materialize), and you're taking some serious money!

ANOTHER BIEL VALUATION MEASURE: QUBT hit $27/share recently, even though their revenue last year ($358k) was half that of BIEL ($715k). Accounting for the difference in outstanding shares (25 bil vs 100 mil), BIEL pps = .10 is the equivalent valuation to QUBT = $27/share.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175566191

Stanford Medicine Carpal Tunnel Study: Should soon be getting the results for "Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis Trial ID: NCT05315297".

Hopefully they'll be as good as the recent Italian carpal tunnel study (published 3-2-25):
Results - All patients showed an improvement in pain level and functional capacity after using ActiPatch for pillar pain management. Additionally, none of the patients experienced pillar pain during the subsequent preventive phase.
Conclusion - The use of ActiPatch proves to be a viable and effective approach for managing and preventing pillar pain in elderly patients with weight-bearing hands who have undergone carpal tunnel release surgery.

PROSPECTUS
BIEL's low-cost OEM business model has put the company in position to be profitable soon (if not already) such that if the upcoming annual report confirms:
1) $800k annual revenue - this will be a significant increase from the the $700k-ish reported the previous two years and get the pps out of the trips;
2) $1.5 million annual revenue (or a $400k quarter) - this will likely achieve cash flow positive/profitability and get the pps to copper.
3) BIEL's prospects for achieving a 1,000% to 10,000% increase in pps are better than any other company on the market right now!
4) The path to profitability will be accelerated by the tax-loss carryforward of about $40 million (no tax on first $40 million profit).

BIEL GOES VIRAL if pps hits .006!
Market cap = $150 million at pps = .006, which would generate massive press (free marketing/advertising) in the news and financial media when they report that the pps increase is better than the gains in Amazon and Apple (3,000% over the past 10 years). It would solve all of BIEL's problems and create numerous opportunities for the company. The Reddit crowd would be all over it (generating massive free online marketing/advertising). If the company then declares profits would be used for a share buyback program (after paying off the loans), the pps would soar ($1+) and the rise would be sustained.

ACTIPATCH WILL BE A "STANDARD OF CARE" PRODUCT!
With FDA clearance for treatment of knee, back, wrist, hips, ankles, plantar fasciitis and all musculoskeletal pain, how can it not, especially at the low price of $35 - with a much longer battery life than the competition! The bashers don't seem to understand that the Actipatch FDA clearance allows it to be sold over the counter (without a prescription). The RecoveryRX applications (post operative pain, edema, wound care, etc.) do require a doctor order. Add in RecoveryRx-Veterinary and you have over 10 billion potential repeat customers - every adult and pet on the planet (every month). Then there is the "wellness" market, as many people use Actipatch for Restless Leg Syndrome (RLS is estimated to affect 10% of adults worldwide), menstrual pain, migraines and other "off label" aches and pains.

RECOVERYRX-VETERINARY COULD/SHOULD BE A GOLDMINE!
The Assisi Loop sells over 300/month just on Amazon @ $329, with 1/20 the battery life. Assisi Loop customers are paying the equivalent of over $6,000 when you factor in the additional cost and lower battery life, but Assisi customers seem happy to pay it based on the numerous 5-star reviews. RecoveryRx/Veterinary should be sold as a two/pack - one for the vagus nerve and the other for the area of pain.

DR. OZ
The Dr. Oz effect will be interesting, considering his recent appointment as Administrator of the Centers for Medicare and Medicaid Services. When Actipatch was featured on the Dr. Oz show, it achieved record sales and sold out the inventory.

BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100). KISS - KEEP IT SIMPLE STUPID! 💋

❤️20 REASONS TO LOVE BIEL❤️
Note: Much of the following was actually provided by the #1 basher - a former Mayflower mover/insurance office staffer/proud AutoCad certificate holder (requires a few days of classes) - who acknowledges BIEL is "very close to profitability every quarter":
1. It's a real company with real products.
2. The company is not burning $$$ millions every quarter trying to get a product through the FDA wringer. They've accomplished FDA clearance (5) already.
3. The company is very close to profitability every quarter. BIEL will likely be profitable soon, it not already (a $400K quarter should do it).
4. There is no toxic debt. The company is not sinking under death spiral financing.
5. Actipatch has thousands of excellent, mostly 5-star customer reviews.
6. $40 million tax-loss carry forward will make the first $40 million in profits tax free and accelerate the path to profitability.
7. If $800k revenue is reported for 2024, it will likely gets the pps out of the trips.
8. Technical indicators (Golden Cross, Blue Sky Breakout, etc.) turning positive. Every bull run starts with this.
9. Bare bones expenses: about $750k/year for GENERAL AND ADMIN EXPENSES (salaries, utilities, R&D, Advertising, etc) with a burn rate of about $220k/year for Other Gen and Admin Expenses.
10. New utility patent (pending) for chronic pain inflammation (vagus nerve) - HUGE.
11. Actipatch will be a Standard of Care product.
12. They have 5 FDA clearances with more pending.
13. Insurance coverage is expanding - currently covered by the UK National Health Service (and Taiwan?).
14. Been in business for over 20 years and never reverse split.
15. Accepted for use by the Veterans Administration.
16. Rapidly expanding in the veterinary/pet market.
17. New contract/partner rumors swirling.
18. Amazon/Apple type of return on investment (ROI) very possible.
19. Fed forecast to cut interest rates five times this year, which benefits OTC stocks like BIEL greatly. The last time this happened (2021) BIEL surged 1,600%.
20. See 1 - 19!

BIEL GONNA RUN LIKE 2021!
Everything is falling into place just like 2021. OTC bull market runs are fueled by the Fed cutting interest rates, and the Fed is now forecast to cut five times this year. Falling interest rates indicate a more accommodative money policy which makes investors more interested in the higher risk/higher reward stocks found on the OTC. The last time this happened, BIEL ran more than 1,600% to .0088. The previous BIEL runs coincided with similar OTC bull markets in 2017, 2014 and 2009.

The technical indicators come first - the Golden Cross and the Blue Sky Breakout. Then the fundamentals kick in (Taiwan, VA, Veterinary, New Zealand...). The OTC bull market has begun, as confirmed by Robinhood (favorite for OTC investors) stock outperforming Goldman Sachs (institutional favorite) 150% to 30% over the past few months. BIEL is a Reddit investors dream. Once they become aware of BIEL (via the financial press), the pps will rocket, product sales will soar, and we'll be celebrating like 2021!
https://microcapdaily.com/exciting-week-for-bioelectronics-corp-otcpink-biel/124825/

Expect a 5,000% ROI (pps = .01 from .0002) if BIEL reports a profit in a few days (2024 Annual Report) - or if management hints Q1 (2025) was profitable. This would put BIEL amongst the all-time greatest stocks.
Gemini says "a 5,000% ROI is fantastic but very rare and typically associated with high-risk investments such as penny stocks or early-stage startups".
Copilot says: "achieving a 5,000% return on investment (ROI) is rare and typically involves high-risk stocks, often in emerging industries or during market booms. Some penny stocks, for example, have been highlighted for their potential to deliver such returns".

BIEL's easiest (and most likely) path to success is to generate a $400k revenue quarter and/or a $1.5 million revenue year. There are indications this has been - or soon will be - achieved. This would achieve cash flow positive/profitability and increase the pps to copper, which would solve most of BIEL's problems and open up a world of opportunities for our company. The analyses provided below demonstrate the connection between revenues, profitability and the pps using standard analysis methods (it ain't rocket science!). Even if only 10% of the "catalysts" identified below materialize, the pps will still hit copper. This would generate a huge amount of free publicity in the financial and news media (an example of capitalism at it's finest - achieving the American Dream!), which would then lead to an exponential increase in product sales. With BIEL's low operating costs and business model, BIEL could pay off their loans quickly and then use subsequent profits to implement an aggressive stock buyback program, which could rocket the pps to $1+!

BIEL IS THE NEXT AMAZON /APPLE (in terms of ROI)!
When BIEL hits .006, the return on investment for a .0002 buy (for those of us fortunate enough to get them recently) will be about the same as the 10-year ROI (3,000%) for Amazon and Apple (stocks I sold too soon). Microsoft 10-year ROI is ONLY 900%. BIEL can hit .006 in IN THE BLINK OF AN EYE, as $1.5 annual revenue (or a $400k quarter) should do it (due to BIEL's extremely low operating costs and business model). There are many indications that this will be accomplished soon, if it hasn't been already! We know that Taiwan, the VA, South Africa and Bulgaria are in progress, as is RecoveryRx-Veterinary in Europe (with the USA pending). Canada is expanding, New Zealand sales started March 1 and hopefully Australia will soon follow. These new revenue streams should be in addition to the $700k+ earned in each of the past two years.

BIEL is a Venture Capitalist Dream! The opportunity to get in on the "next big thing", but with a company that has been in business for over 20 years (rather than a start-up). BIEL is probably the closest that any of us will get to having a venture capital kind of opportunity.
1) BIEL products have Standard of Care pain management potential for every adult and pet on the planet.
2) BIEL has 5 FDA clearances (with more pending) and the products work extremely well (some say like a miracle).
3) Upside ROI is huge (>10,000%) with minimal downside risk!
4) BIEL should be able to use their China manufacturer to ship directly to their international distributors and Viant for their USA sales to avoid tariffs.

BIEL HITS COPPER WHEN THE FOLLOWING OCCURS!
pps > .001 after management drops some positive hints. The Golden Cross (already achieved) and Blue Sky Breakout will get the technicians/chartists/Reddit crowd attention and the pps out of the trips;
pps > .01 after management drops some positive hints that convinces investors that break even/cash flow positive (annual rev = $1.5 mil) will be achieved, combined with the momentum from a 2021 like OTC run (fueled by the Reddit crowd);
pps > .04 after pr indicates the annual revs from Taiwan (in progress) can be valued at $10 mil+;
pps > .08 after pr indicates the annual revs from the VA (in progress) can be valued at $10 mil+;
pps > .12 after pr indicates the annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil+;
pps > .16 after pr indicates the annual revs from new contracts (distributors, partners, New Zealand, etc.) can be valued at $10 mil+;
Above pps values are based on P/E = 100
For P/E = 200, pps = .32
For P/E = 300, pps = .48
pps > $1 after loans are paid off and a stock buyback is initiated.

CATALYSTS (Details):
If 2024 revenues are over $800,000 (report is due in the coming days), it would be a significant improvement over the $700k-ish reported in each of the last two years, which would propel the pps out of the trips. It would also generate some positive publicity in the financial media that would spur future product sales. With the huge USA market available to BIEL last year - after KT previously tried to weaponize their exclusive US rights (2022 and 2023) against us - increased revenue is likely.

$1.5 million annual revenue (or a $400k quarter) = break even, cash flow positive: PPS = .01.

Taiwan looks like it will be the first catalyst. There are over 80 public hospitals and over 400 private hospitals in Taiwan. They have national health insurance and are rated the world's number one health system.
Assume 100 Taiwan hospitals order 100 Actipatch/RecoveryRx per month @$100 each for BIEL:
$100 x 100 hospitals x 100 x 12 mo = $12,000,000 rev/year.
Using profit = $10 mil and P/E = 100: PPS = .04.
Note: RecoveryRx Veterinary also appears to be in play in Taiwan.

1000 Veterinarian Clinics (USA):
Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi):
1000 x 100 x 10 x 12 = $12,000,000 rev/year.
Note: RecoveryRx Veterinary also appears to be in play internationally.

There are over 1,000 VA facilities in the U.S. Conservatively assuming 100 VA hospitals order 100 RecoveryRx per month ($100 each for BIEL):
100 x 100 x 100 x 12 = $12,000,000 rev/year.

Sub-total for VA + VET = $20 mil and P/E = 100: PPS = .08!

TOTAL (Taiwan + VA + Veterinary + applying the tax loss carryforward):
pps = .12 (P/E = 100)
pps = .24 (P/E = 200)
pps = .36 (P/E = 300)

Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, RecoveryRx Veterinary international sales, New Zealand, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = $1).

BIEL FACT CHECK:
1) The nearly 25 billion shares outstanding is large but not a problem. It is irrelevant as it is accounted for in the VALUATION (pps) - 25 billion shares @.0002 = $5 million is the same valuation as 1 million shares at $5/share. FULL STOP

The stock market is all about valuation (outstanding shares x pps) - you buy if you think a stock is under-valued and sell if you think it is over-valued. Only amateurs/newbies do not understand this. Right now, investors feel BIEL is fairly valued between $5 - 7.5 million, but if news develops where investors feel $1 billion is fair value, you will see the BIEL pps rise accordingly (pps = .04). Apple and Amazon will soon have billions more shares outstanding than BIEL (and nobody is concerned)!

Some have tried to dispute this - without success - always changing the subject to dilution. BIEL has not diluted significantly in many years, and there is no indication it will in the future.

The low pps is actually an advantage at this point, as it makes BIEL affordable to any investor. If you have $1,200 to invest, would you rather own 6 million shares of BIEL or 1 share of O'Reilly Auto Parts? The Reddit crowd would definitely choose BIEL.

2) BIEL's valuation is currently $5 million (for revs of $715k last year), which is undervalued compared to stocks (like SERV and QUBT for example) with billion-dollar valuations but only half of BIEL's revenue.

When people become aware of the benefits of PSWT/PEMF and the huge multi-billion-dollar drug free pain management market - that desperately needs FDA cleared Actipatch/RecoveryRx/RecoveryRx Veterinary- BIEL will SOAR!

3) BIEL has been in business for over 20-years and has NEVER done a reverse split, which is VERY IMPRESSIVE!

4) Supply/Demand - the majority of the outstanding shares are in tight hands, so the pps will move up like a rocket after ignition, as the supply of available shares will be less than the demand (SQUEEZE!). Shareholders can help fuel the blast off by locking up their shares with "good until cancelled sell orders" (@$1) so their shares cannot be borrowed by the short sellers, thereby further reducing the supply.

BUYOUT
Right now, I doubt anything under $50 million would be considered (accounting for loans, etc.). That's out of my range, but in the future - after the pps increases, loans are paid off and a share buyback is implemented - I could see a point where a group of shareholders could get together and leverage their shareholdings to make an offer. Years ago, Simpsonly and some other shareholders made an offer to Andy but were turned down. Not sure if Orel Hershiser was part of that group, but he is rumored to be a shareholder and a big fan of the products (would be a great influencer for BIEL).

BIEL THE NEXT MSFT?
Those that bought one share of Microsoft at the IPO price of $21 saw their investment increase to $210,000 recently (10,000 X). Someone buying 1 million shares of BIEL @.0002 would see their $200 investment grow to $2,000,000 (pps = $2) with equivalent growth. Is this possible? Absolutely, after BIEL becomes profitable, pays off their loans and then implements an aggressive stock buyback program!

3331 is restricted to one post per day, which is often deleted.

Is srin OK. Maybe he needs to be checked on.

It seems his posts are more comical every day.

Is your head spinning srin? Been to the doctor lately?

There is no Board of Directors because there is no Corporation.

There is no Corporation because the Corporation is Forfeited.

https://egov.maryland.gov/businessexpress/entitysearch

Koneru, Whelan, and Staelin can't vote on anything and they can't change anything. They can hold unofficial meetings on Zoom and share a Wordle screen but they can't hold an actual BOD Meeting because there is no Corporation.

Yes, on Zoom, because Koneru is in California.

LOL, you quoted Whelan saying "as we execute our strategy." Calling it a "strategy" is being generous. She spends hours every day on FaceBook posting free ads that nobody sees and flaming shareholders on the Group page, and she's soliciting Researchers to do free research.

That's like a halftime interview with a coach who's losing big.... "We just have to execute our strategy." But if that strategy sucks, and/or if the coach is inept?


BIEL

This company is on fyah. Anyone looking in at this turd do your research first is my honest opinion here. Many many many have lost $$$$$ here. Management is almost unbearable with their stinking silence. But there are still a few pumptards here daily spewing things like we are going to go to the moon. Lol

Sell volume today 83 times the buys volume.😃

424/25, Buy: 250,000, Neutral: 4,140,000, Sell: 20,770,000..😭

Sree joined BIEL as a BOD member 5 months ago, still there.

>

Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation
December 03, 2024 08:15 ET

FREDERICK, Md., Dec. 03, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL, a developer of medical technology products, today announces that Sree Koneru, PhD, will join its Board of Directors, effective December 3, 2024. Upon Dr. Koneru’s appointment, the Board will consist of three members, including Kelly Whelan, President of BioElectronics, and its Chairman, Richard Staelin, PhD.

"We are honored to welcome Sree Koneru to the Board. Sree brings a rich depth of experience in medical device development. We welcome his insight as we execute our strategy," said Kelly Whelan, President of BioElectronics Corporation.

"I am honored to join the Board of Directors at BioElectronics, a company at the forefront of innovations in neuromodulation," said Sree Koneru, "The Company’s role in pioneering non-pharmacological solutions for pain management and other chronic disease states, aligns with my passion for improving lives through advances in neuromodulation technology. I look forward to contributing to the success and transformative impact of the incredible technology manufactured and distributed by BioElectronics Corporation."

"As we continue to pursue our mission of focusing on R&D aimed at delivering non-pharmacological solutions for acute, chronic and neuropathic pain, Sree is the ideal addition to our Board to help guide our growth as we scale efficiently, while also reaching new markets," said Richard Staelin, PhD, Chairman of the Board of BioElectronics Corporation. "We are thrilled to have Sree join the Board, and we look forward to working together."

Dr. Koneru is Director of Program Management for a contract manufacturing organization that specializes in the design & development of wearable and implantable active electronic medical devices. In his previous role, Sree served as the VP of Product Development for BioElectronics Corporation, where he was responsible for prototype development, physiological testing/clinical evaluation, and regulatory submissions, culminating in several approvals from the US FDA and a CE marking. He also managed the product life cycle from conception to retail launch for domestic and international channel partners.

Sree obtained his doctoral degree in Biomedical Engineering ('15) from the State University of New York at Binghamton, NY- USA. He has a background in bringing Neuromodulation (Electroceuticals) medical devices to market, with research expertise in investigating physiological responses (prototype development and clinical research) of pulsed radiofrequency electromagnetic fields. His vision is to be an industry leader in developing transcutaneous, percutaneous, implantable, and electromagnetic neuromodulation technologies, intended to treat chronic diseases.

Banjo, there probably is no insider buying' because WHO is exactly left 'inside'? ie who is left working in this company? The sales rep is gone. Siree is gone. No PR person. Staelin has loans, so his skin is in the game and evidently seems not interested in buying shares. The CEO sure is not buying, as that would be known publicly. Obviously she knows how bad this is going and is not risking buying stock. This is sadly a one person operation so THAT 'insider' seems not interested in 'buying'.

Such an embarrassment of a PUBLICLY TRADED CORPORATION!

😭SALES-TRACK SHOWS STEEP SALES DECLINES FOR BIEL.😭

Hold on for a few more day's to really see what Bioelectronic Corporation Financial's show!!

Well bobby, zombie biel is a one trick pony and no one is buying the trick. That's the reason the financials have not been released. No sales. The buying public has caught on.

Answer's to your POST can be found at post's by 3331 (very informative about Bioelectronic's potential)!!!

Well bobby, it seems to me that the biel longs are waiting for a miracle. Even with a good financial report, the 24 billion shares will keep the price per share in the crapper. Why hasn't there been any insider buying for years if the price is so good and the prospects so promising? The longs have saddled a dead horse.

LOL, is that first statement of how great the selling is going on in the UK, as 'factual' as the imaginary, hopeful and prayerful numbers you plug into the financials, that will make this company successful and profitable? Maybe you should provide some verifiable references to prove how successful these products are selling in the UK.

Yeah LOL, you are right, this message board is very 'entertaining'!

ACTIPATCH HOT SELLER IN THE UK - CHEMIST4U LABELS IT A "TOP SELLER" (WITH SOME VERSIONS SOLD OUT). RECOVERY WAVE SOLD OUT AT HEALTHANDCARE. FABULOUS REVIEWS! HOPEFULLY PERFORMING AS WELL IN TAIWAN, NEW ZEALAND, USA, CANADA, ETC.

ISN'T THIS FUN? IT'S SO ENTERTAINING TO WATCH THE BASHERS TURN ON EACH OTHER!

PROSPECTUS
BIEL's low-cost OEM business model has put the company in position to be profitable soon (if not already) such that if the upcoming annual report confirms:
1) $800k annual revenue - this will be a significant increase from the the $700k-ish reported the previous two years and get the pps out of the trips;
2) $1.5 million annual revenue (or a $400k quarter) - this will likely achieve cash flow positive/profitability and get the pps to copper.
3) BIEL's prospects for achieving a 1,000% to 10,000% increase in pps are better than any other company on the market right now!
4) The path to profitability will be accelerated by the tax-loss carryforward of about $40 million (no tax on first $40 million profit).

BIEL GOES VIRAL if pps hits .006!
Market cap = $150 million at pps = .006, which would generate massive press (free marketing/advertising) in the news and financial media when they report that the pps increase is better than the gains in Amazon and Apple (3,000% over the past 10 years). It would solve all of BIEL's problems and create numerous opportunities for the company. The Reddit crowd would be all over it (generating massive free online marketing/advertising). If the company then declares profits would be used for a share buyback program (after paying off the loans), the pps would soar ($1+) and the rise would be sustained.

ACTIPATCH WILL BE A "STANDARD OF CARE" PRODUCT!
With FDA clearance for treatment of knee, back, wrist, hips, ankles, plantar fasciitis and all musculoskeletal pain, how can it not, especially at the low price of $35 - with a much longer battery life than the competition! The bashers don't seem to understand that the Actipatch FDA clearance allows it to be sold over the counter (without a prescription). The RecoveryRX applications (post operative pain, edema, wound care, etc.) do require a doctor order. Add in RecoveryRx-Veterinary and you have over 10 billion potential repeat customers - every adult and pet on the planet (every month). Then there is the "wellness" market, as many people use Actipatch for Restless Leg Syndrome (RLS is estimated to affect 10% of adults worldwide), menstrual pain, migraines and other "off label" aches and pains.

RECOVERYRX-VETERINARY COULD/SHOULD BE A GOLDMINE!
The Assisi Loop sells over 300/month just on Amazon @ $329, with 1/20 the battery life. Assisi Loop customers are paying the equivalent of over $6,000 when you factor in the additional cost and lower battery life, but Assisi customers seem happy to pay it based on the numerous 5-star reviews. RecoveryRx/Veterinary should be sold as a two/pack - one for the vagus nerve and the other for the area of pain.

DR. OZ
The Dr. Oz effect will be interesting, considering his recent appointment as Administrator of the Centers for Medicare and Medicaid Services. When Actipatch was featured on the Dr. Oz show, it achieved record sales and sold out the inventory.

BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100). KISS - KEEP IT SIMPLE STUPID! 💋

❤️20 REASONS TO LOVE BIEL❤️
Note: Much of the following was actually provided by the #1 basher - a former Mayflower mover/insurance office staffer/proud AutoCad certificate holder (requires a few days of classes) - who acknowledges BIEL is "very close to profitability every quarter":
1. It's a real company with real products.
2. The company is not burning $$$ millions every quarter trying to get a product through the FDA wringer. They've accomplished FDA clearance (5) already.
3. The company is very close to profitability every quarter. BIEL will likely be profitable soon, it not already (a $400K quarter should do it).
4. There is no toxic debt. The company is not sinking under death spiral financing.
5. Actipatch has thousands of excellent, mostly 5-star customer reviews.
6. $40 million tax-loss carry forward will make the first $40 million in profits tax free and accelerate the path to profitability.
7. If $800k revenue is reported for 2024, it will likely gets the pps out of the trips.
8. Technical indicators (Golden Cross, Blue Sky Breakout, etc.) turning positive. Every bull run starts with this.
9. Bare bones expenses: about $750k/year for GENERAL AND ADMIN EXPENSES (salaries, utilities, R&D, Advertising, etc) with a burn rate of about $220k/year for Other Gen and Admin Expenses.
10. New utility patent (pending) for chronic pain inflammation (vagus nerve) - HUGE.
11. Actipatch will be a Standard of Care product.
12. They have 5 FDA clearances with more pending.
13. Insurance coverage is expanding - currently covered by the UK National Health Service (and Taiwan?).
14. Been in business for over 20 years and never reverse split.
15. Accepted for use by the Veterans Administration.
16. Rapidly expanding in the veterinary/pet market.
17. New contract/partner rumors swirling.
18. Amazon/Apple type of return on investment (ROI) very possible.
19. Fed forecast to cut interest rates five times this year, which benefits OTC stocks like BIEL greatly. The last time this happened (2021) BIEL surged 1,600%.
20. See 1 - 19!

BIEL GONNA RUN LIKE 2021!
Everything is falling into place just like 2021. OTC bull market runs are fueled by the Fed cutting interest rates, and the Fed is now forecast to cut five times this year. Falling interest rates indicate a more accommodative money policy which makes investors more interested in the higher risk/higher reward stocks found on the OTC. The last time this happened, BIEL ran more than 1,600% to .0088. The previous BIEL runs coincided with similar OTC bull markets in 2017, 2014 and 2009.

The technical indicators come first - the Golden Cross and the Blue Sky Breakout. Then the fundamentals kick in (Taiwan, VA, Veterinary, New Zealand...). The OTC bull market has begun, as confirmed by Robinhood (favorite for OTC investors) stock outperforming Goldman Sachs (institutional favorite) 150% to 30% over the past few months. BIEL is a Reddit investors dream. Once they become aware of BIEL (via the financial press), the pps will rocket, product sales will soar, and we'll be celebrating like 2021!
https://microcapdaily.com/exciting-week-for-bioelectronics-corp-otcpink-biel/124825/

Expect a 5,000% ROI (pps = .01 from .0002) if BIEL reports a profit in a few days (2024 Annual Report) - or if management hints Q1 (2025) was profitable. This would put BIEL amongst the all-time greatest stocks.
Gemini says "a 5,000% ROI is fantastic but very rare and typically associated with high-risk investments such as penny stocks or early-stage startups".
Copilot says: "achieving a 5,000% return on investment (ROI) is rare and typically involves high-risk stocks, often in emerging industries or during market booms. Some penny stocks, for example, have been highlighted for their potential to deliver such returns".

BIEL's easiest (and most likely) path to success is to generate a $400k revenue quarter and/or a $1.5 million revenue year. There are indications this has been - or soon will be - achieved. This would achieve cash flow positive/profitability and increase the pps to copper, which would solve most of BIEL's problems and open up a world of opportunities for our company. The analyses provided below demonstrate the connection between revenues, profitability and the pps using standard analysis methods (it ain't rocket science!). Even if only 10% of the "catalysts" identified below materialize, the pps will still hit copper. This would generate a huge amount of free publicity in the financial and news media (an example of capitalism at it's finest - achieving the American Dream!), which would then lead to an exponential increase in product sales. With BIEL's low operating costs and business model, BIEL could pay off their loans quickly and then use subsequent profits to implement an aggressive stock buyback program, which could rocket the pps to $1+!

BIEL IS THE NEXT AMAZON /APPLE (in terms of ROI)!
When BIEL hits .006, the return on investment for a .0002 buy (for those of us fortunate enough to get them recently) will be about the same as the 10-year ROI (3,000%) for Amazon and Apple (stocks I sold too soon). Microsoft 10-year ROI is ONLY 900%. BIEL can hit .006 in IN THE BLINK OF AN EYE, as $1.5 annual revenue (or a $400k quarter) should do it (due to BIEL's extremely low operating costs and business model). There are many indications that this will be accomplished soon, if it hasn't been already! We know that Taiwan, the VA, South Africa and Bulgaria are in progress, as is RecoveryRx-Veterinary in Europe (with the USA pending). Canada is expanding, New Zealand sales started March 1 and hopefully Australia will soon follow. These new revenue streams should be in addition to the $700k+ earned in each of the past two years.

BIEL is a Venture Capitalist Dream! The opportunity to get in on the "next big thing", but with a company that has been in business for over 20 years (rather than a start-up). BIEL is probably the closest that any of us will get to having a venture capital kind of opportunity.
1) BIEL products have Standard of Care pain management potential for every adult and pet on the planet.
2) BIEL has 5 FDA clearances (with more pending) and the products work extremely well (some say like a miracle).
3) Upside ROI is huge (>10,000%) with minimal downside risk!
4) BIEL should be able to use their China manufacturer to ship directly to their international distributors and Viant for their USA sales to avoid tariffs.

BIEL HITS COPPER WHEN THE FOLLOWING OCCURS!
pps > .001 after management drops some positive hints. The Golden Cross (already achieved) and Blue Sky Breakout will get the technicians/chartists/Reddit crowd attention and the pps out of the trips;
pps > .01 after management drops some positive hints that convinces investors that break even/cash flow positive (annual rev = $1.5 mil) will be achieved, combined with the momentum from a 2021 like OTC run (fueled by the Reddit crowd);
pps > .04 after pr indicates the annual revs from Taiwan (in progress) can be valued at $10 mil+;
pps > .08 after pr indicates the annual revs from the VA (in progress) can be valued at $10 mil+;
pps > .12 after pr indicates the annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil+;
pps > .16 after pr indicates the annual revs from new contracts (distributors, partners, New Zealand, etc.) can be valued at $10 mil+;
Above pps values are based on P/E = 100
For P/E = 200, pps = .32
For P/E = 300, pps = .48
pps > $1 after loans are paid off and a stock buyback is initiated.

CATALYSTS (Details):
If 2024 revenues are over $800,000 (report is due in the coming days), it would be a significant improvement over the $700k-ish reported in each of the last two years, which would propel the pps out of the trips. It would also generate some positive publicity in the financial media that would spur future product sales. With the huge USA market available to BIEL last year - after KT previously tried to weaponize their exclusive US rights (2022 and 2023) against us - increased revenue is likely.

$1.5 million annual revenue (or a $400k quarter) = break even, cash flow positive: PPS = .01.

Taiwan looks like it will be the first catalyst. There are over 80 public hospitals and over 400 private hospitals in Taiwan. They have national health insurance and are rated the world's number one health system.
Assume 100 Taiwan hospitals order 100 Actipatch/RecoveryRx per month @$100 each for BIEL:
$100 x 100 hospitals x 100 x 12 mo = $12,000,000 rev/year.
Using profit = $10 mil and P/E = 100: PPS = .04.
Note: RecoveryRx Veterinary also appears to be in play in Taiwan.

1000 Veterinarian Clinics (USA):
Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi):
1000 x 100 x 10 x 12 = $12,000,000 rev/year.
Note: RecoveryRx Veterinary also appears to be in play internationally.

There are over 1,000 VA facilities in the U.S. Conservatively assuming 100 VA hospitals order 100 RecoveryRx per month ($100 each for BIEL):
100 x 100 x 100 x 12 = $12,000,000 rev/year.

Sub-total for VA + VET = $20 mil and P/E = 100: PPS = .08!

TOTAL (Taiwan + VA + Veterinary + applying the tax loss carryforward):
pps = .12 (P/E = 100)
pps = .24 (P/E = 200)
pps = .36 (P/E = 300)

Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, RecoveryRx Veterinary international sales, New Zealand, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = $1).

BIEL FACT CHECK:
1) The nearly 25 billion shares outstanding is large but not a problem. It is irrelevant as it is accounted for in the VALUATION (pps) - 25 billion shares @.0002 = $5 million is the same valuation as 1 million shares at $5/share. FULL STOP

The stock market is all about valuation (outstanding shares x pps) - you buy if you think a stock is under-valued and sell if you think it is over-valued. Only amateurs/newbies do not understand this. Right now, investors feel BIEL is fairly valued between $5 - 7.5 million, but if news develops where investors feel $1 billion is fair value, you will see the BIEL pps rise accordingly (pps = .04). Apple and Amazon will soon have billions more shares outstanding than BIEL (and nobody is concerned)!

Some have tried to dispute this - without success - always changing the subject to dilution. BIEL has not diluted significantly in many years, and there is no indication it will in the future.

The low pps is actually an advantage at this point, as it makes BIEL affordable to any investor. If you have $1,200 to invest, would you rather own 6 million shares of BIEL or 1 share of O'Reilly Auto Parts? The Reddit crowd would definitely choose BIEL.

2) BIEL's valuation is currently $5 million (for revs of $715k last year), which is undervalued compared to stocks (like SERV and QUBT for example) with billion-dollar valuations but only half of BIEL's revenue.

When people become aware of the benefits of PSWT/PEMF and the huge multi-billion-dollar drug free pain management market - that desperately needs FDA cleared Actipatch/RecoveryRx/RecoveryRx Veterinary- BIEL will SOAR!

3) BIEL has been in business for over 20-years and has NEVER done a reverse split, which is VERY IMPRESSIVE!

4) Supply/Demand - the majority of the outstanding shares are in tight hands, so the pps will move up like a rocket after ignition, as the supply of available shares will be less than the demand (SQUEEZE!). Shareholders can help fuel the blast off by locking up their shares with "good until cancelled sell orders" (@$1) so their shares cannot be borrowed by the short sellers, thereby further reducing the supply.

BUYOUT
Right now, I doubt anything under $50 million would be considered (accounting for loans, etc.). That's out of my range, but in the future - after the pps increases, loans are paid off and a share buyback is implemented - I could see a point where a group of shareholders could get together and leverage their shareholdings to make an offer. Years ago, Simpsonly and some other shareholders made an offer to Andy but were turned down. Not sure if Orel Hershiser was part of that group, but he is rumored to be a shareholder and a big fan of the products (would be a great influencer for BIEL).

BIEL THE NEXT MSFT?
Those that bought one share of Microsoft at the IPO price of $21 saw their investment increase to $210,000 recently (10,000 X). Someone buying 1 million shares of BIEL @.0002 would see their $200 investment grow to $2,000,000 (pps = $2) with equivalent growth. Is this possible? Absolutely, after BIEL becomes profitable, pays off their loans and then implements an aggressive stock buyback program!

3331 is restricted to one post per day, which is often deleted.

Well Art, the real problem IS we shareholders are in the dark about LOSSES - Just maybe we might get great numbers????

I think the REAL question is, when this pattern continues and the most probable end result occurs due to continuing losses, what will all these 'pumpers' do?

Yup, that’s the one.




BUY $BIEL$